iCellate sets a new standard for marker-independent processing technology for cell samples for medical diagnosis as well as basic and clinical research. The technique provides better quality of the sample by removing unwanted cells and other impurities naturally, while optimizing the density of cells of interest for downstream applications, whether for establishing cancer diagnosis, innovative cancer research or developing new and revolutionary health products. The technology supports a safer and more effective diagnosis of cancer today and enables a paradigm shift in health care tomorrow.